PRDX4 and colon adenocarcinoma: Moreover, we also found that PRDX4 was associated with multiple clinical characteristics, including age, sex, pathological subtype, lymph node metastasis, etc., suggesting that PRDX4 may be a potential prognostic marker for COAD.